Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Dec 15, 2021 11:56am
155 Views
Post# 34233069

RE:RE:RE:What is (or may be) changing over the next 2 -3 weeks ?

RE:RE:RE:What is (or may be) changing over the next 2 -3 weeks ?Great response MM.  I too feel that the likely deal will be with Baxter for the appetizer, main, dessert, drinks, fine wines and other libations.  I also think that as the dinner progresses and Baxter is in awe of the feast they will potentially decide to pick up everything during the dinner.  In fact they may have made that arrangement already - we shareholders don't know.

I do find it curious that - with the lack of disclosure of the full Baxter deal - heavily redacted - that management and governance have been able to deal in both shares and warrants for almost two years now.  I always thought that securities laws precluded insiders from dealing until such time as all material news and events have been disclosed to all and its a level playing field from an information perspective for all parties.

The Baxter information must be material as why would it be hidden if minor or incidental?  And if it had been disclosed would the share price have gone from $0.80 per share to around $0.20 per share now?  Could it have gone much higher than the $0.80 per share on that information?
<< Previous
Bullboard Posts
Next >>